News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
MedTech Barcelona amplía su cartera de productos, ofreciendo soluciones personalizadas en biotecnología celular
MedTech Barcelona Presents New Customizable Solutions in Cellular Biotechnology
Healthcare · Access to innovation
MedTech Barcelona is expanding its portfolio with new solutions that meet industry needs and…
Científico investigando con un microscopio
How TruSight Oncology 500 v2 is helping advance cancer research at the Catalan Institute of Oncology
Healthcare
Líder mundial en genómica, Illumina ofrece soluciones integrales de secuenciación de nueva…
Secuencia de ADN junto a un reloj para representar la genética aplicada al envejecimiento
Genetics applied to healthy aging becomes a reality with N-GENE
Healthcare
Various studies estimate that genetic factors explain between 20–30% of the variability in lifespan…
Logo de Klinea
Klinea is a B Corp
Corporate
The engineering solutions development company for the pharmaceutical and biotechnology sector is…
Presentación de los resultados de BIOTRAIM de BIOHOPE en el el World Transplant Congress 2025
Biohope presents the results of the BIOTRAIM study on the use of pretransplant Immunobiogram® at the World Transplant Congress 2025 and they are selected among the most relevant abstracts in kidney transplantation
Healthcare
Immunobiogram® is a test that measures in vitro the sensitivity (response) of each patient's immune…
Banner con los logos de las empresas participantes en el proyecto LUMINA
Flomics Biotech joins Eurostars project LUMINA to advance lung cancer recurrence detection using liquid biopsy and AI
Healthcare
The project, which launched on June 1, 2025, aims to develop an innovative platform for the non-…
Dos mujeres sonriendo
ORYZON receives European Medicines Agency approval to initiate a Phase Ib study of iadademstat in sickle cell disease
Healthcare · Advanced therapies
First iadademstat clinical trial in non-malignant hematological indications.
Un nuevo hito conseguido: se recluta al primer paciente para el ensayo fase III en cirrosis hepática descompensada.
New milestone for Mikrobiomik: recruits first patient in its LiverGut Phase III trial for decompensated liver cirrhosis
Healthcare · Access to innovation
The biotechnology company Mikrobiomik has begun patient recruitment for LiverGut, the first…
La sede de Oryzon
ORYZON reports financial results and corporate update for half-year ending June 30, 2025
Healthcare
Between December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0…